Publication | Closed Access
Nattokinase atherothrombotic prevention study: A randomized controlled trial
24
Citations
22
References
2021
Year
Results of this trial show that nattokinase supplementation has a null effect on subclinical atherosclerosis progression in healthy individuals at low risk for CVD.
| Year | Citations | |
|---|---|---|
Page 1
Page 1